Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ZANUBRUTINIB, with a corresponding US DMF Number 38215.
Remarkably, this DMF maintains an Active status since its submission on March 31, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 08, 2023, and payment made on May 30, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II